• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas)

$4,500.00 – $9,000.00

Clear
SKU: KLI4939202 Categories: Diagnostics Market Research, Oncology & Hematology Market Reports Pages: 880
  • Description
  • Table of Contents
  • Latest reports

Description

Molecular diagnostics is becoming a dominant platform in clinical medicine and represents one of the fastest growing segments of the IVD market.  As analyst Shara Rosen, R.T., MBA. details, in recent years years the number of assays introduced has been growing at a remarkable clip.  This report, The World Market for Molecular Diagnostics (Infectious Disease, Oncology, Blood Screening, Pre-Natal and Other Areas) represents the fifth time that Kalorama has conducted a complete study into the market for molecular diagnostics.

Comprehensive Coverage of the Molecular Diagnostics Industry

The report not only contains current market data for business planning, it goes beyond the numbers to fully assess what is going on in the market and why. Since the last edition of this report, a lot has changed, and a lot has stayed the same. There is intense competition but also opportunities for entrants in some areas.   As part of its coverage, the report includes the following:

  • Over 800 Pages of Detailed Market Coverage
  • Over 55 Tables Makes Market Analysis More Accessible
  • Current Market Size and Forecast 2012-2017 for Several Molecular IVD Segments (Infectious Disease, Blood Screening, Histology, Oncology, Prenatal, Coagulation, Tissue Typing, Inherited Diseases, Pharmacodiagnostics and Other)
  • Infectious Disease Molecular Sales by Disease (Hepatitis, HIV, GC/Chlamydia, HAI, Respiratory, Organism ID, Mycobacteria/TB, others)
  • Over 200 Profiles of Molecular Diagnostic Competitors
  • Recent Mergers and Acquisitions
  • Revenues of Test Service Companies
  • Geographic Breakout of the Molecular Diagnostics Market by Region (North America, Europe, China, Japan, ROW)
  • Sample Prep Market, 2012 and 2017
  • Breakout of Molecular Histology/Cytology Market (in situ hybridization, HPV, Tissue Microarrays), 2012 and 2017

More and more laboratories offer complex panels of tests that help physicians evaluate disease risk and make therapeutic decisions. Government and private healthcare payers have recognized the value of new molecular tools and have agreed to pay for them.   A desire for better and faster test results, a preference for tests that are aimed at the patent, renewed interest in IVD in general and more particularly in molecular IVD has led to the commercialization of a number of technological tools that make more sensitive and specific tests possible. Some of these technological innovations include cost-effective, multiplexed testing platforms coupled with high-powered software capabilities. In addition analyses using saliva, urine, and blood instead of biopsied tissue make for more patient-friendly test systems.

Over 200 Companies Profiled and Ranked

 

Kalorama provides profiles of over 200 companies participating in the market. All of these companies have different strategies and compete in different areas, and Kalorama acknowledges this by separating the companies in a triage system based on where they stand in the molecular in vitro diagnostics market.

  • “IVD Leaders” – The top IVD companies participating in molecular diagnostics as well as dominating the rest of testing.
  • “Molecular Diagnostics Leaders” -The top companies focused on molecular testing.
  • “Molecular Diagnostics  Participants”– Molecular diagnostic companies that are by now established in the market
  • “Promising Companies”- Those companies that have potential with an innovative approach
  • “Molecular Diagnostics Newcomers”– IVD Companies that have novel or interesting approaches to keep an eye on
  • “Platform Innovators”– Companies that have developed new platform technologies
  • “Information Technology Companies” – Molecular testing relies on strong information systems to handle data.  These companies are in the forefront.
  • “Sample Prep Leaders” – Companies focused on sample preparation for molecular diagnostics
  • “Specialist Companies” – In various areas (microbiology, histology, blood banking, etc)

 

A Realistic Look at The Need-To-Know Trends
Molecular diagnostics is a complicated market that requires a thorough analysis to understand. Many reports make bold predictions which later are proved incorrect by market events. In this report, Kalorama Information provides revenues and market forecasts, but also looks deeply at some of the trends in the market and what might impact results in the future. The report summarizes what is working and what is not working in the past few years.

  • Sequencing Hype and Reality: Innovations in DNA Sequencing, Key Players and its Future in Clinical Medicine
  • Pharmacodiagnostics and Where it Stands in 2013
  • The Latest Growth Numbers of LDTs, regulatory activity, and their impact on the Market
  • IVD Directive Update
  • Patent Issues
  • Healthcare Reform, Accountable Care Organizations and Reimbursement Trends
  • Improvements in Platforms
  • Developments in ISH testing, Tissue Microarrays and Mass Spectroscopy
  • Integrated Sample-to-Results Testing

Market size and forecasts in the report are for manufacturer’s revenues. Secondary and primary resources, including: trade publications, annual report and interviews with key executives in molecular diagnostics were used for this study.

All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

Introduction

Scope and Methodology

Size and Growth of the Market

Market Trends

CHAPTER TWO: INTRODUCTION

Background

Developments since 2000

New Platforms

Test Quality Control

Building a Strong Future

The Service Industry Makes Gains

The $1000 Genome

Information Technology and “Apps”

Miniaturization and Multiplexed Assays

Integrated Sample–to-Results Testing

Mass Spectrometry

Tests and Technologies in 2012

CHAPTER THREE: THE COMMERCIALIZATION CONUNDRUM

Background

Commercialization of Molecular Tests

Regulatory Issues and Molecular Assays

Patent Litigation Abounds

Consumer, Payer and Physician Acceptance

Clinical Molecular Test Reimbursement Coding in The U.S.

CHAPTER FOUR: SEQUENCING – HYPE AND REALITY

Background

Companies and Technologies

PCR Not Ready To Take the Back Seat

Pathogen sequencing

Prenatal Fetal Chromosomal Analysis

CHAPTER FIVE: MARKET ANALYSIS: WORLD MARKETS

Background

Market Estimate and Forecast by Region

The United States

RUO/IUO Issues

The Patient Protection and Affordable Care Act

Accountable Care Organizations

Europe

IVD Directive Update

China

India

CHAPTER SIX: THE MARKET FOR BLOOD MARKERS IN CANCER

Overview

Methylation Patterns

Other Tests

Blood Molecular Test Market and Forecasts

LDTs

Radiotherapy Testing

CHAPTER SEVEN: THE MARKET FOR MOLECULAR ASSAYS IN HEMATOLOGY

Flow Cytometry

CHAPTER EIGHT: THE MARKET FOR MOLECULAR ASSAYS IN COAGULATION AND CARDIAC CARE

Thrombophilia SNPs

MTHFR

Factor V

CYP4V2

Market and Forecast

Coagulation Molecular Research Projects

Pharmacodiagnostics

Market for PGx testing

Plavix Testing

CHAPTER NINE: HISTOLOGY AND CYTOLOGY

Overview

in situ hybridization

HPV Testing

Tissue Microarrays

Circulating Tumor Cells

Chromosome Analysis

Pharmacodiagnostic Histology

CHAPTER TEN: MICROBIOLOGY AND VIROLOGY

Overview

Microbiology Market and Forecast

Role of ID Testing in the Molecular Diagnostics Market

Markets for Specific Infectious Disease Tests

Genome Sequencing

Roche, Illumina and Life

Other Systems

Mass Spectrometry

Major Companies

Market Estimate

Blood Culture

HIV

Market and Forecast

Hepatitis

Market and Forecast

Sexually Transmitted Diseases (STDs)

Hospital Acquired Infections (HAIs)

Market and Forecast

Respiratory Tract Infections

Tuberculosis

Market and Forecast

Fungal Infections

CHAPTER ELEVEN: THE MARKET FOR MOLECULAR ASSAYS IN BLOOD TRANSFUSION MEDICINE

Blood Pathogen Screening

Market and Forecast

Blood Typing

Molecular Blood Typing

CHAPTER TWELVE: THE MARKET FOR MOLECULAR ASSAYS IN ORGAN TRANSPLANT MANAGEMENT

HLA Typing

Stem Therapy Matching

HLA Market and Forecast

CHAPTER THIRTEEN: THE MARKET FOR MOLECULAR ASSAYS IN PRENATAL AND NEONATAL TESTING

Overview

Market and Forecast

FISH testing

Other Developments

Neonatal Testing

CHAPTER FOURTEEN: THE MARKET FOR MOLECULAR ASSAYS FOR INHERITED DISEASES

Arthritis

Gastrointestinal Conditions

Diabetes

Cardiovascular Disease

Alzheimer’s Disease

Parkinson’s Disease

Psychiatric Disorders

Autism

CHAPTER FIFTEEN: CONCLUSIONS AND STRATEGIC IMPLICATIONS – 2012 AND BEYOND

Expectations and Realities

Four Issues That Will Impact Market Success

CHAPTER SIXTEEN: COMPETITIVE ANALYSIS

Companies and Vendors to Watch

Acquisitions, Alliances and Collaborations

Looking Beyond Borders

CHAPTER SEVENTEEN: COMPANY PROFILES: TOP TIER IVD COMPANIES’ MOLECULAR BUSINESSES

Abbott Diagnostics

Recent Revenue History

HLA

Molecular Histology

Companion Tests

Molecular Diagnostics

Infectious Diseases – Molecular

IntelligentMDx Alliance

PLEX-ID

Alere

Recent Revenue History

ARKRAY

Beckman Coulter Inc./Danaher Fullerton, CA www.beckmancoulter.com

Recent Revenue History

Instrumentation

Becton, Dickinson and Company (BD)

Recent Revenue History

The BD MAX Enterprise

Viper System

Molecular Microbiology

BD GeneOhm

Histology

Oncology, etc.

bioMérieux Inc.

Recent Revenue History

Molecular Oncology

The Biocartis Program

Molecular Microbiology

NucliSENS

Product Development

Bio-Rad Laboratories Inc.

Recent Revenue History

Gen-Probe Inc.

Recent Revenue History

Product development

Expansion

Prostate Cancer

STDs

Panther System

HPV

Transplant/HLA testing

Infectious Diseases

Blood Bank

Hologic, Inc.

Recent Revenue History

Instrumentation Laboratory (IL)

Recent Revenue History

Ortho Clinical Diagnostics

Recent Revenue History

QIAGEN N.V.

Recent Revenue History

Market Expansion

Histology

Infectious diseases

Rotor-Gene

Oncology/Personalized Medicine

TB

HPV

HLA

Automation for the Future

Women’s Health

Point of Care

Sequencing

Roche Diagnostics Indianapolis, IN www.roche.com

Recent Revenue History

Miscellaneous

Viral Load

STDs

Companion Tests

Sample Preparation

Tissue Diagnostics

Blood Bank

Sequencing

Microarrays

Siemens Healthcare Diagnostics

Recent Revenue History

Histology

Molecular

Sequencing

Companion Tests

Sysmex Corporation

Recent Revenue History

Thermo Fisher Scientific Inc.

Recent Revenue History

Allergy

CHAPTER EIGHTEEN: COMPANY PROFILES: MAJOR MOLECULAR TEST COMPANIES

Affymetrix, Inc.

Histology

Whole Genome Analysis

Agilent Technologies Inc.

Research Products

Asuragen, Inc.

Oncology

Inherited Diseases

Controls

Sample Collection

Sequencing

Beijing Genome Institute (BGI)

BGI Projects

BioFire Diagnostics, Inc.

Respiratory Panel

Environmental Testing

Caliper Life Sciences

Clinical Diagnostics

Sequencing

Life Sciences

Celera Diagnostics

Cepheid

Market Expansion

HAI

Personalized Medicine

TB

Infectious Diseases

Eiken Chemical Co., Ltd

Enzo Biochem Inc.

ColonSentry

Alliances

IP Protection

Epigenomics AG

Fluidigm Corporation

Prenatal

Illumina Inc.

BeadXpress

Sequencing

Cytogenetics

Sample Prep

PCR

CLIA Lab Service

Ipsogen SA

Life Technologies

Ion Torrent Systems

Personalized Medicine

PCR

Arrays

IVD Company Deals

Life and Quidel develop diagnostics on the 7500 Fast Dx

Sepsis

HIV

Informatics

International Presence

Novartis Diagnostics

Blood Bank

International Programs

Blood Typing

Molecular IVDs

Companion Tests

PerkinElmer, Inc.

Prenatal and Neonatal Screening

Personalized Medicine

Molecular and Sequencing Diagnostics

Test Services

Human Health Research

RainDance Technologies, Inc.

Product Development

Seegene, Inc.

Instrumentation

Transgenomic, Inc.

Lab Services

Diagnostic Tools Division

CTCs

Sequencing

CHAPTER NINETEEN: MARKET PARTICIPANTS

Alacris Theranostics GmbH

Astra Biotech GmbH

Autogenomics Inc.

Biocartis SA

Biofortuna Ltd.

Biotype Diagnostic GmbH

BlueGnome

DiaGenic ASA

DiagnoCure

ELITech Group

EraGen Biosciences Inc.

Genetic Technologies Limited

Victoria, Australia

www.gtglabs.com

GenMark Diagnostics Inc.

Helicos BioSciences

IRIS International, Inc.

Cytology

Luminex Corporation

IVD Expansion

Cystic Fibrosis

MAGPIX Multiplexing

Meridian Bioscience, Inc.

Bioline

Nanosphere, Inc.

Infectious Diseases

Hospital Acquired Infections

Sony DADC Biosciences

Cell Sorting

Mass Spectrometry

TrimGen Genetic Technology

TrovaGene, Inc.

Prenatal

CHAPTER TWENTY: PROMISING COMPANIES

Ahram Biosystems, Inc.

Allegro Diagnostics Corp

Amoy Diagnostics Co. Ltd.

Anagnostics Bioanalysis GmbH

Sample Preparation

Applied BioCode, Inc.

ArcticDx Inc.

Ariosa Diagnostics

Axela Inc.

BioHelix Corporation

BioNanomatrix/ BioNano Genomics

BJS Biotechnologies

DiagCor Bioscience Inc. Ltd.

DxTerity Diagnostics Inc.

Epistem plc

Exiqon A/S

Exonhit

GeneNews Limited

Genome Diagnostics BV (GenDx)

Genomica S.A.U.

Genorama Ltd.

Great Basin Corporation

Health Discovery Corporation (HDC)

IncellDx, Inc.

Insight Genetics

IntegenX Inc.

Sample Transport

Linkage Biosciences, Inc.

Med BioGene, Inc. (MBI)

Multiplicom

NABsys, Inc.

Nanostring Technologies, Inc.

NIPD Genetics Ltd

OptiGene Ltd

Orion Genomics

Oxford Gene Technology (OGT)

PrimeraDx

Rheonix Inc.

Skyline Diagnostics B.V.

Spartan Bioscience Inc.

Stratos Genomics Inc.

VolitionRx Limited

WaferGen Biosystems, Inc.

CHAPTER TWENTY ONE: MOLECULAR NEWCOMERS

DiaSorin S.p.A.

Fujirebio Diagnostics, Inc.

GE Healthcare

Cell Imaging

Molecular Sequencing

Phadia AB

Quidel Corporation

Alliances

Randox Laboratories Ltd.

TOSOH Corporation

Transasia Bio-Medicals Ltd.

CHAPTER TWENTY TWO: TEST PLATFORM INNOVATIONS

Advanced Liquid Logic, Inc. (ALL)

Aquila Diagnostic Systems

Canon U.S. Life Sciences (CLS)

DNA Medicine Institute (DMI)

Espira, Inc.

Genia Technologies Inc.

Genisphere

Lumora Ltd.

Michigan State University

NobleGen Biosciences

Oxford Nanopore Technologies Ltd.

QuantuMDx Group Limited

SensiQ Technologies, Inc.

Thermal Gradient, Inc.

Vela Diagnostics (VelaDx)

CHAPTER TWENTY THREE: SAMPLE PREPARATION SUPPLIERS

Arcxis Biotechnologies

Argylla Technologies LLC

Biomatrica, Inc.

Fluoresentric, Inc.

New England Biolabs, Inc. (NEB)

NorDiag

Norgen Biotek Corp.

Phthisis Diagnostics

PreAnalytiX GmbH

QIAGEN N.V.

Streck

ZyGEM Corp. Ltd.

CHAPTER TWENTY FOUR: COMPANY PROFILES: INFORMATION TECHNOLOGY SPECIALISTS

Access Genetics

CLC bio

CollabRx, Inc.

Definiens

DNA Direct

DIYGenomics

GenoSpace, LLC

HolGenTech Inc.

Ingenuity Systems

MediSapiens Ltd.

NextBio

Personalis

Portable Genomics

Sciclips

Selventa

Sophic Systems Alliance

Wellpoint Inc.

CHAPTER TWENTY FIVE: MICROBIOLOGY SPECIALISTS

Advanced Biological Laboratories (ABL)

AdvanDx, Inc.

Akonni Biosystems Inc.

Sample Preparation

Test Systems

Biomagnetics Diagnostics Corporation

BlackBio S.L.

Bruker BioSciences Corporation

CapitalBio Corporation

Ceeram S.A.S.

Cooperative Diagnostics, LLC

Curetis AG

Enigma Diagnostics Limited

Focus Diagnostics, Inc.

GenoID Ltd.

Great Basin Scientific, Inc.

Hain Lifescience GmbH

HiberGene Diagnostics Ltd

Ibis Biosciences

iCubate Incorporated

Immunexpress Group

InDevR

Ingen Biosciences SA

Intelligent Medical Devices, Inc. (IMDx)

IQuum Inc.

Miacom Diagnostics GmbH

MicroPhage, Inc.

Mobidiag Ltd

Molecular Detection Inc. (MDI)

Molzym GmbH & Co. KG

Myconostica

nanoMR Inc.

NetBio

PathGEN Dx Pte. Ltd.

PathoGene

Pathogenica

SIRS-Lab

T2 Biosystems

CHAPTER TWENTY SIX: BLOOD BANK SPECIALISTS

AbSorber AB

AXO Science

GMS Biotech

Grifols, S.A.

Immucor, Inc.

Progenika Inc.

CHAPTER TWENTY SEVEN: COMPANIES SPECILAIZING IN CIRCULATING TUMOR CELLS

ApoCell, Inc.

Biocept, Inc.

Clearbridge BioMedics

Cynvenio Biosystems, Inc.

On-Q-ity

RareCyte, Inc.

ScreenCell

Veridex, LLC

CHAPTER TWENTY EIGHT: COMPANY PROFILES: HISTOLOGY

SPECIALISTS

Advanced Cell Diagnostics

Biocare Medical, LLC

ChipDX, LLC

Cymogen Dx, LLC

Dako A/S

Alliances

Companion Diagnostics

Horizon Discovery Ltd

HTG Molecular Diagnostics

Automation

Mitomics Inc.

Norchip

CHAPTER TWENTY NINE: COMPANY PROFILES: SELECTED TEST SERVICE PROVIDERS

23andMe

Agendia BV

Market Expansion

Product News

AltheaDx Diagnostics, Inc.

Ambry Genetics

Aria Diagnostics, Inc. (formerly Ariosa Diagnostics)

ARUP Laboratories

AssureRx Health, Inc.

Avesthagen Limited

Bio-Reference Laboratories, Inc. (BRLI)

bioTheranostics

Bostwick Laboratories

CardioDx, Inc.

Caris Life Sciences

Castle Biosciences Inc.

CBLPath

Chronix Biomedical Inc.

Clarient Inc.

CombiMatrix Molecular Diagnostics, Inc.

Complete Genomics

Crescendo Bioscience, Inc.

deCode genetics ehf

Gene Variants

DermaGenoma, Inc.

Diagnósticos da América (DASA)

Diatherix Laboratories Inc.

EXACT Sciences Corporation

Exosome Diagnostics

Genelex Corporation

Genetadi Biotech SL

Genomic Health, Inc.

Service Spin off

Expansion

Sequencing

Information Technology

Genoptix Medical Laboratory

GenoVive LLC

Inostics GmbH

IntegraGen SA

Interleukin Genetics, Inc.

Knome, Inc.

Lab21 Limited

Services

Products Division

Expansion

Laboratory Corporation of America Holdings (LabCorp)

LifeCodexx AG

Lineagen Inc.

Lumigenix

Mayo Medical Laboratories

MDxHealth SA (formerly Oncomethylome Sciences)

Medical Diagnostic Laboratories L.L.C. (MDL)

Myriad Genetics, Inc

Alliances

Test Information

Patent Issues

Natera Inc.

Navigenics

NewGene

Pathway Genomics

Pathwork Diagnostics

PGXL Laboratories

Precision Therapeutics

Prometheus Laboratories Inc.

Patent Issues

Quest Diagnostics

Information Technology

Ridge Diagnostics, Inc.

Rosetta Genomics Ltd.

Rules-Based Medicine, Inc. (RBM)

Sequenom Inc.

Sequenom Center for Molecular Medicine

Market Expansion

Prenatal Patent

Genetic Analysis Products

Sequenta, Inc.

Signal Genetics

Sonic Healthcare

SureGene, LLC

Veracyte. Inc.

Verinata Health, Inc.

XDx Inc. – Expression Diagnostics

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume II: Viral Disease

    $1,496.00 – $2,992.00
  • Placeholder image

    Clinical Diagnostics in India – Market Sector Analyses and Participant Directory

    $4,500.00 – $9,990.00
  • Placeholder image

    Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Global Orthopedic Trauma Device Market (Screws and Plates, IM Fixation,...The U.S. Market for Rx to OTC Switches, 6th Edition
Scroll to top